Growth Opportunities in the United States' $7+ Billion Ophthalmic Eye Droppers Market, 2025-2033 [Yahoo! Finance]
LENZ Therapeutics, Inc. (LENZ)
Company Research
Source: Yahoo! Finance
Dublin, Nov. 07, 2025 (GLOBE NEWSWIRE) -- The "United States Ophthalmic Eye Dropper Market Report by Type, Drug Type, Treatment Type, States and Company Analysis, 2025-2033" has been added to ResearchAndMarkets.com's offering. The United States Ophthalmic Eye Dropper Market is expected to grow from US$ 4.58 billion in 2024 to US$ 7.13 billion in 2033. The growth is a huge opportunity in the healthcare industry, boosted by innovation in eye care products and rising cases of eye-related disorders. The market is anticipated to post a Compound Annual Growth Rate (CAGR) of 5.05% during the period from 2025 to 2033, reflecting changing consumer demand and improvements in delivery systems. Ophthalmic eye droppers have gained immense popularity with growing awareness of eye care and mounting incidence of ocular disorders. With the increasing aging population and the commonality of chronic diseases demanding frequent eye therapy, the use of these droppers has become a necessity in everyda
Show less
Read more
Impact Snapshot
Event Time:
LENZ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LENZ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LENZ alerts
High impacting LENZ Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
LENZ
News
- LENZ Therapeutics Announces MFDS Submission of New Drug Application for LNZ100 (VIZZ™) in South Korea for the Treatment of PresbyopiaGlobeNewswire
- LENZ Therapeutics to Present at Upcoming Investor Conferences [Yahoo! Finance]Yahoo! Finance
- LENZ Therapeutics to Present at Upcoming Investor ConferencesGlobeNewswire
- LENZ Therapeutics (NASDAQ:LENZ) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.MarketBeat
- Insider Spends US$239k Buying More Shares In LENZ Therapeutics [Yahoo! Finance]Yahoo! Finance
LENZ
Earnings
- 11/5/25 - Beat
LENZ
Sec Filings
- 11/19/25 - Form 4
- 11/17/25 - Form 144
- 11/14/25 - Form SCHEDULE
- LENZ's page on the SEC website